Early-onset ankylosing spondylitis is associated with a functional MICA polymorphism

被引:65
作者
Amroun, H
Djoudi, H
Busson, M
Allat, R
El Sherbini, SM
Stoma, I
Ramasawmy, R
Brun, M
Dulphy, N
Krishnamoorthy, R
Toubert, A
Charron, D
Abbadi, MC
Tamouza, R
机构
[1] Hop St Louis, Lab Immunol & Histocompatibilite, CIB HOB, AP HP,IUH, F-75010 Paris, France
[2] Hop St Louis, INSERM U662, F-75010 Paris, France
[3] Inst Pasteur, Immunol Lab, Algiers, Algeria
[4] EHS Doneva, Serv Rhumatol, Algiers, Algeria
[5] Hop Robert Debre, INSERM U458, F-75019 Paris, France
关键词
spondyloarthropathies; early-onset; MICA; polymorphism;
D O I
10.1016/j.humimm.2005.09.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Major histocompatibility complex (MHC) class I chain-related A (MICA) molecules deliver activating signals through the NKG2D receptor expressed on the surface of natural killer (NK), CD8 alpha beta and gamma delta T cells, and the MICA gene is polymorphic. The recently described MICA amino acid substitution at position 129 (MICA-129) seems to affect its binding to NKG2D. We investigated whether this dimorphism (MICA-129met [methionine] and MICA-129val [valinel]) is associated with susceptibility to ankylosing spondylitis (AS) in a cohort of Algerian patients stratified according to their HLAB27 status and the age of onset of the disease. DNA from 129 patients and 76 healthy individuals were analyzed to determine the HLA-B generic type as well as MICA-129 polymorphism. Statistical analysis revealed: (1) a weaker association between AS and HLA-B27 in Algerians than in that reported for European patients (63% versus 80-90%), suggesting a possible influence of other genetic/environmental determinants in the Studied population and (2) an association between MICA-129 met/met genotype and juvenile AS (p = 0.02) independent of HLA-B27 status. These data Suggest a potential role for a functionally relevant MICA gene polymorphism in autoimmune/inflammatory disease susceptibility.
引用
收藏
页码:1057 / 1061
页数:5
相关论文
共 15 条
  • [1] MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function
    Das, H
    Groh, V
    Kuijl, C
    Sugita, M
    Morita, CT
    Spies, T
    Bukowski, JF
    [J]. IMMUNITY, 2001, 15 (01) : 83 - 93
  • [2] THE EUROPEAN-SPONDYLARTHROPATHY-STUDY-GROUP PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF SPONDYLARTHROPATHY
    DOUGADOS, M
    VANDERLINDEN, S
    JUHLIN, R
    HUITFELDT, B
    AMOR, B
    CALIN, A
    CATS, A
    DIJKMANS, B
    OLIVIERI, I
    PASERO, G
    VEYS, E
    ZEIDLER, H
    [J]. ARTHRITIS AND RHEUMATISM, 1991, 34 (10): : 1218 - 1227
  • [3] Prevalence, clinical relevance and characterization of circulating cytotoxic CD4+CD28- T cells in ankylosing spondylitis
    Duftner, C
    Goldberger, C
    Falkenbach, A
    Würzner, R
    Falkensammer, B
    Pfeiffer, KP
    Maerker-Hermann, E
    Schirmer, M
    [J]. ARTHRITIS RESEARCH & THERAPY, 2003, 5 (05) : R292 - R300
  • [4] Polymorphism in MICA rather than HLA-B/C genes is associated with psoriatic arthritis in the Jewish population
    González, S
    Brautbar, C
    Martínez-Borra, J
    López-Vazquez, A
    Segal, R
    Blanco-Gelaz, MA
    Enk, CD
    Safriman, C
    López-Larrea, C
    [J]. HUMAN IMMUNOLOGY, 2001, 62 (06) : 632 - 638
  • [5] Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rhe'umatoid arthritis
    Groh, V
    Brühl, A
    El-Gabalawy, H
    Nelson, JL
    Spies, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (16) : 9452 - 9457
  • [6] Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells
    Groh, V
    Rhinehart, R
    Randolph-Habecker, J
    Topp, MS
    Riddell, SR
    Spies, T
    [J]. NATURE IMMUNOLOGY, 2001, 2 (03) : 255 - 260
  • [7] Genetic aspects of ankylosing spondylitis
    Khan, MA
    Ball, EJ
    [J]. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2002, 16 (04): : 675 - 690
  • [8] NKG2D blockade prevents autoimmune diabetes in NOD mice
    Ogasawara, K
    Hamerman, JA
    Ehrlich, LR
    Bour-Jordan, H
    Santamaria, P
    Bluestone, JA
    Lanier, LL
    [J]. IMMUNITY, 2004, 20 (06) : 757 - 767
  • [9] OTO K, 1998, AM J OPHTHALMOL, V126, P436
  • [10] Ricci-Vitiani L, 2000, J RHEUMATOL, V27, P2193